A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Grand Rounds Bookmark and Share

Grand Rounds

The Grand Rounds Program offered at City of Hope is available to physicians and hospitals in the surrounding areas. Members of the medical staff at City of Hope are available to speak to medical groups, hospital medical staffs and community hospital health-care professionals on a variety of topics related to cancer and other life-threatening diseases.
 
Our speakers can provide expert presentations in various settings, including hospital grand rounds, luncheon and dinner lectures, and CME conferences and symposia. New speakers and topics are added regularly, and we can create custom presentations to meet the specific needs of your organization.
 
In addition to those shown here, speakers on a variety of other topics are available. Please contact us for more information: cme@coh.org or 626-218-5622.
 
 
Topics
 
Anatomic Pathology
 
Central Nervous System
Brain Tumors, Benign
Brain Tumors, Malignant
Brain Tumors, Metastatic
CNS Lymphoma
Pituitary Tumors
Spinal Tumors

Clinical Cancer Genetics
Genetic Counseling
 
Clinical Molecular Diagnostics
Advances in Testing
Familial Cancer Testing
Hereditary Colon Cancer
Li-Fraumeni Syndrome (the largest clinical experience to date)
Marfan Syndrome
X-link Mental Retardation (a panel of eight genes may detect the underlying mechanism in about 20 percent of families)
 
Diabetes
Islet Cell Transplantation
 
Gastrointestinal Cancers
Anal Cancer
Bile Duct Cancer
Colon Cancer
Esophageal Cancer
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumors
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Small Intestine Cancer
 

Genitourinary Cancers
Bladder Cancer
Kidney Cancer
Prostate Cancer
Testicular Cancer
 
Head and Neck Cancers
Laryngeal Cancer
Oral Cancer

Hematologic Malignancies
Aplastic Anemia
Hematopoietic Stem Cell Transplantation
Leukemia, Acute Lymphoblastic
Leukemia, Acute Myeloid
Leukemia, Acute Promyelocytic
Leukemia, Chronic Lymphocytic
Leukemia, Chronic Myelogenous
Lymphoma, Primary CNS
Lymphoma, Hodgkin’s
Lymphoma, Non-Hodgkin’s
Multiple Myeloma
Myelodysplastic Syndromes
Plasma Cell Neoplasms

Infectious Diseases
Worldwide Swine Flu (AH1N1) Outbreak - CME Module
 
Musculoskeletal Cancers
Bone and Soft Tissue
Sarcomas and Other Soft Tissue Cancers
 
Myasthenia Gravis
Robotic Thymectomy
 
Pain Management and Palliative Care
 
Pediatric Cancers
Bone and Soft Tissue Cancer
Childhood Brain Tumor
Leukemia, Childhood Acute Lymphoblastic
Leukemia, Childhood Acute Myeloid
Liver Cancer, Childhood
Lymphoma, Childhood Hodgkin’s Disease
Lymphoma, Childhood Non-Hodgkin’s
Neuroblastoma
Sarcoma
 
Skin Cancer
Melanoma

Thoracic Cancers
Lung Cancer, Non-small Cell
Lung Cancer, Small Cell
Mediastinal Tumors
Mesothelioma

Thyroid Cancer

Women’s Cancers
Breast Cancer
Cervical Cancer
Endometrial/Uterine Cancer
Ovarian Epithelial Cancer
Ovarian Germ Cell Tumor
 
 

 

 

Grand Rounds

Grand Rounds

The Grand Rounds Program offered at City of Hope is available to physicians and hospitals in the surrounding areas. Members of the medical staff at City of Hope are available to speak to medical groups, hospital medical staffs and community hospital health-care professionals on a variety of topics related to cancer and other life-threatening diseases.
 
Our speakers can provide expert presentations in various settings, including hospital grand rounds, luncheon and dinner lectures, and CME conferences and symposia. New speakers and topics are added regularly, and we can create custom presentations to meet the specific needs of your organization.
 
In addition to those shown here, speakers on a variety of other topics are available. Please contact us for more information: cme@coh.org or 626-218-5622.
 
 
Topics
 
Anatomic Pathology
 
Central Nervous System
Brain Tumors, Benign
Brain Tumors, Malignant
Brain Tumors, Metastatic
CNS Lymphoma
Pituitary Tumors
Spinal Tumors

Clinical Cancer Genetics
Genetic Counseling
 
Clinical Molecular Diagnostics
Advances in Testing
Familial Cancer Testing
Hereditary Colon Cancer
Li-Fraumeni Syndrome (the largest clinical experience to date)
Marfan Syndrome
X-link Mental Retardation (a panel of eight genes may detect the underlying mechanism in about 20 percent of families)
 
Diabetes
Islet Cell Transplantation
 
Gastrointestinal Cancers
Anal Cancer
Bile Duct Cancer
Colon Cancer
Esophageal Cancer
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumors
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Small Intestine Cancer
 

Genitourinary Cancers
Bladder Cancer
Kidney Cancer
Prostate Cancer
Testicular Cancer
 
Head and Neck Cancers
Laryngeal Cancer
Oral Cancer

Hematologic Malignancies
Aplastic Anemia
Hematopoietic Stem Cell Transplantation
Leukemia, Acute Lymphoblastic
Leukemia, Acute Myeloid
Leukemia, Acute Promyelocytic
Leukemia, Chronic Lymphocytic
Leukemia, Chronic Myelogenous
Lymphoma, Primary CNS
Lymphoma, Hodgkin’s
Lymphoma, Non-Hodgkin’s
Multiple Myeloma
Myelodysplastic Syndromes
Plasma Cell Neoplasms

Infectious Diseases
Worldwide Swine Flu (AH1N1) Outbreak - CME Module
 
Musculoskeletal Cancers
Bone and Soft Tissue
Sarcomas and Other Soft Tissue Cancers
 
Myasthenia Gravis
Robotic Thymectomy
 
Pain Management and Palliative Care
 
Pediatric Cancers
Bone and Soft Tissue Cancer
Childhood Brain Tumor
Leukemia, Childhood Acute Lymphoblastic
Leukemia, Childhood Acute Myeloid
Liver Cancer, Childhood
Lymphoma, Childhood Hodgkin’s Disease
Lymphoma, Childhood Non-Hodgkin’s
Neuroblastoma
Sarcoma
 
Skin Cancer
Melanoma

Thoracic Cancers
Lung Cancer, Non-small Cell
Lung Cancer, Small Cell
Mediastinal Tumors
Mesothelioma

Thyroid Cancer

Women’s Cancers
Breast Cancer
Cervical Cancer
Endometrial/Uterine Cancer
Ovarian Epithelial Cancer
Ovarian Germ Cell Tumor
 
 

 

 
Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
 
 
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.


NEWS & UPDATES
  • Every summer, hospitals nationwide experience a shortage of blood donations. This summer is no exception. Nearly 1.7 million new cancer cases are expected to be diagnosed in the U.S. this year,  and many of those patients will need blood transfusions during their treatment. Patients at City of Hope alone rely o...
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...